Chembio Diagnostics Investor Relations Material
Latest events
Q3 2022
Chembio Diagnostics
Q4 2022
29 Mar, 2023
Investor Presentation
2 Jan, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Chembio Diagnostics Inc
Access all reports
Chembio Diagnostics Inc. is a biotechnology company specializing in the development, manufacturing, and commercialization of point-of-care diagnostic products. The company focuses on delivering diagnostic solutions for infectious diseases and other medical conditions. Its offerings utilize proprietary technologies to provide rapid, accurate results in healthcare settings, aiming to support clinical decision-making and public health efforts. Its portfolio encompasses diagnostic assays, devices, and related components tailored to specific testing requirements. Chembio Diagnostics Inc. is headquartered in Hauppauge, New York, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CEMI
Country
🇺🇸 United States